We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Premier Research Appoints Executive Director
News

Premier Research Appoints Executive Director

Premier Research Appoints Executive Director
News

Premier Research Appoints Executive Director

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Premier Research Appoints Executive Director"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Premier Research Group has announced the appointment of Etienne Drouet to the position of Executive Director, Oncology Europe.

In this position, Mr. Drouet will play a leading role in the operations, strategic planning and corporate development of Premier Research’s growing portfolio of oncology business.

“Etienne brings a tremendous amount of operational knowledge and oncology acumen serving the needs of our customers,” said Dr. Sue Stansfield, Executive VP, Clinical Development.

Dr. Ludo Reynders added, “Having worked with Etienne before, I am pleased to have someone of his caliber lead our European oncology team.”

Mr. Drouet offers practical insight to oncology clinical trials with more than 19 years in drug development including 14 years in clinical research and five years as a research scientist.

Mr. Drouet has held positions of increasing responsibility at pharmaceutical, contract research, and investigational cooperative groups including Rhône Poulenc Rorer (Sanofi Aventis), Icon, and Breast Cancer International Research Group.

His extensive oncology experience and expertise has ensured timely, efficient program delivery.

He holds a Biotechnology Engineering degree from the European Engineering School of Biotechnology and a Master in Science degree from the University Louis Pasteur.

Advertisement